A three-year study of tirzepatide – a medication approved ... such as high blood pressure or heart disease. Like similar drugs, it’s used as a shot patients give themselves once a week and ...
For patients with heart failure with preserved ejection fraction ... in a late-stage trial that its GLP-1/GIP treatment tirzepatide cut the risk of adverse HF outcomes by 38% versus placebo.
New study results found weight loss and diabetes drugs Zepbound and Mounjaro may significantly cut the risk of ... study that found its drug tirzepatide slashed the risk of developing type 2 ...
Share on Pinterest Could sleeping in on the weekends help lower heart disease risk? Anna Malgina/Stocksy “Catching up” on sleep over the weekend could reduce the risk of heart disease by 20% ...
New research finds that people who catch up on z’s on their days off can cut their risk of heart disease by up to 20%. “Sufficient compensatory sleep is linked to a lower risk of heart disease ...
In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...
Mounjaro, Zepbound Cut Odds for ... 10 mg or 15 mg of tirzepatide for 176 weeks (three years). Participants were deemed to be prediabetic if they had conditions such as heart disease, high blood ...
Share on Pinterest A new study reports that people with coronary artery disease can lower their heart attack risk by 44% by quitting ... Short, clear-cut messages are needed for smokers at every ...
“Catching up” on sleep over the weekend could reduce the risk of heart disease by 20%, a new study suggests. Sleep deprivation — often defined as less than 7 hours a night — can present a ...